key: cord-0967715-vz3cf0qu
authors: Phakey, Akshay; Gabbie, Susie
title: Response to “SARS‐CoV‐2 Testing and Outcomes in the First 30 Days after the First Case of COVID‐19 at an Australian Children's Hospital”
date: 2020-05-23
journal: Emerg Med Australas
DOI: 10.1111/1742-6723.13560
sha: 26dc9605b3643014f16bad39a9965f8781bd727c
doc_id: 967715
cord_uid: vz3cf0qu

nan

Ibrahim et al highlighted a very low number of SARS-CoV-2 positive cases in their tertiary paediatric setting 1 . We congratulate the authors on encompassing the whole presenting cohort of children who were tested, and would like to make a contribution from the vantage point at our hospital trust, providing emergency and urgent primary care in London, U.K., where the incidence of COVID-19 has been high and community transmission is well established.

The authors underlined that a high proportion of patients who were SARS-CoV-2 negative had comorbidities. We contrast this with our experience in London, where we found a sizeable proportion of paediatric cases had comorbidities. We carried out an internal prospective cohort study, tracking the clinical and demographic characteristics of all paediatric patients (age 0-18 years) with a positive combined pernasal-throat swab for Sars-CoV-2 RNA during March and April 2020. We had 18 cases of a positive report, of which 9/18 (50%) had one or more comorbidities, including fibrosarcoma, autoimmune neutropenia, anorexia nervosa, developmental disorder, and bacterial co-infections (aspiration pneumonia, perineal cellulitis, acute appendicitis). We wish to reiterate the vulnerability of children with pre-existing illness or immunocompromised states.

We believe that adult caregivers may continue to pose a hazard to chronically ill children in periods of school closures. The U.K. lockdown came into force on March 17. Nevertheless, 8/18 (44%) of our positive cohort had an adult family member who met the case definition prior to onset of illness, suggesting that either (i) in our local remains narrow, children contaminated with SARS-CoV-2 with mild or atypical symptoms will continue to be potential invisible carriers who could thwart efforts to shield more vulnerable populations.

In summary, we believe the authors' findings combined with our own make a case for policymakers to broaden the case definition for COVID-19 to include headache and skin rashes in children, as this would help containment efforts. Fever remained the predominant symptom but was not universally present, and therefore its use as a screening tool may generate false negatives.

SARS-CoV-2 Testing and Outcomes in the First 30 Days after the First Case of COVID-19 at an Australian Children's Hospital

Accepted Article in Spain with 375 cases